Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
Molecular Insight Pharmaceuticals, Inc. (MIPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2011 8-K Quarterly results
05/04/2011 8-K Form 8-K - Current report
04/20/2011 8-K Form 8-K - Current report
03/16/2011 8-K Form 8-K - Current report
03/08/2011 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi...
Docs: "Plan Support Agreement between Molecular Insight Pharmaceuticals, Inc. and Certain Holders of Bonds, and effective March 1, 2011",
"DIP Commitment Letter between Molecular Insight Pharmaceuticals, Inc. and Certain Holders of Bonds and Their Affiliate Entities, and effective March 1, 2011",
"Exit Commitment Letter between Molecular Insight Pharmaceuticals, Inc. and Certain Holders of Bonds and Their Affiliate Entities, and effective March 1, 2011",
"Molecular Insight Accepts Alternative Transaction Proposal and Files Amended Plan of Reorganization"
02/18/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Monthly Operating Report of Molecular Insight Pharmaceuticals, Inc. for the period January 1, 2011 through January 31, 2011 submitted to the Office of the United States Trustee"
02/08/2011 8-K Form 8-K - Current report
01/26/2011 8-K Form 8-K - Current report
01/24/2011 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12/29/2010 8-K Form 8-K - Current report
12/21/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Molecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB™ Marketplace"
12/14/2010 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Trigg...
Docs: "Investment Agreement, between Molecular Insight Pharmaceuticals, Inc. and Savitr Capital LLC",
"Severance Agreement, between Molecular Insight Pharmaceuticals, Inc. and Daniel L. Peters, with resignation effective on December 8, 2010",
"Severance Agreement, between Molecular Insight Pharmaceuticals, Inc. and Charles H. Abdalian, Jr., with resignation effective on December 8, 2010",
"Consulting Agreement, between Molecular Insight Pharmaceuticals, Inc. and Harry Stylli",
"Interim Services Agreement between Molecular Insight Pharmaceuticals, Inc. and Tatum, a division of SFN Professional Services LLC",
"Molecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management Changes"
11/19/2010 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Media"
11/04/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Molecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational Results Cambridge, MA, November 4, 2010 - Molecular Insight Pharmaceuticals, Inc. , a biopharmaceutical company discovering and developing targeted therapeutic and imaging radiopharmaceuticals for use in oncology, today announced the financial and operational results for the third quarter ended September 30, 2010."
11/03/2010 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Media"
10/22/2010 8-K Form 8-K - Current report
10/19/2010 8-K Form 8-K - Current report
10/15/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Media"
10/08/2010 8-K Form 8-K - Current report
10/06/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Media"
09/17/2010 8-K Form 8-K - Current report
09/09/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Media"
09/01/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Media"
08/17/2010 8-K Form 8-K - Current report
08/04/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2010 Financial and Operational Results Cambridge, MA, August 4, 2010 - Molecular Insight Pharmaceuticals, Inc. , a biopharmaceutical company discovering and developing targeted therapeutic and imaging radiopharmaceuticals for use in oncology, today announced the financial and operational results for the second quarter ended June 30, 2010."
08/02/2010 8-K Form 8-K - Current report
07/16/2010 8-K Form 8-K - Current report
07/02/2010 8-K Form 8-K - Current report
06/25/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "Media"
06/22/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Media"
05/18/2010 8-K Form 8-K - Current report
05/17/2010 8-K Form 8-K - Current report
05/06/2010 8-K Form 8-K - Current report
04/27/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Media"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy